10-F088621 - 4-chloro-2-ethoxy-5-methoxy-pyrimidine | 1353979-91-5
Benzenepropanoic acid, α-[[(5S)-5-[3-chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenyl]-6-(5-fluoro-2-furanyl)thieno[2,3-d]pyrimidin-4-yl]oxy]-2-[[1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]methoxy]-, (αR)-
CAS:Formula:C39H37ClF4N6O6SPurity:98%Color and Shape:SolidMolecular weight:829.2593S 63845
CAS:S 63845 is a novel anti-cancer drug that belongs to the class of ubiquitin ligases. It has been shown to induce apoptosis in cancer cells and inhibit tumor growth in vivo. S 63845 also inhibits the phosphorylation of cyclin D2, which may be a potential biomarker for sclerosing cholangitis (SCC). This compound is highly cytotoxic and has been found to be effective against subcutaneous tumors in mice. S 63845 also inhibits the proliferation of primary cells and has been shown to significantly reduce hepatic steatosis, as well as inhibiting inflammation caused by toll-like receptor 4 activation.Formula:C39H37ClF4N6O6SPurity:Min. 95%Color and Shape:SolidMolecular weight:829.26 g/molS63845
CAS:S63845 is a selective myeloid leukemia 1(MCL1) inhibitor that binds to human MCL1 with a Kd of 0.19 nM.Cost-effective and quality-assured.Formula:C39H37ClF4N6O6SPurity:97.7% - ≥98%Color and Shape:SolidMolecular weight:829.26Ref: IN-DA0037O4
1g125.00€5g209.00€10g311.00€25g701.00€100gTo inquire50mg31.00€100mg43.00€250mg61.00€Benzenepropanoic acid, α-[[(5S)-5-[3-chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy]-2-[[2-(2-methoxyphenyl)-4-pyrimidinyl]methoxy]-, (αR)-
CAS:Formula:C47H44ClFN6O6SPurity:99%Color and Shape:SolidMolecular weight:875.4053(E)-2-(benzo[d]thiazol-2-yl)-3-(4-(dimethylamino)phenyl)acrylonitrile
CAS:Purity:98%Molecular weight:305.3999938964844(E)-2-(1,3-Benzothiazol-2-yl)-3-[4-(dimethylamino)phenyl]prop-2-enenitrile
CAS:(E)-2-(1,3-Benzothiazol-2-yl)-3-[4-(dimethylamino)phenyl]prop-2-enenitrilePurity:≥95%Molecular weight:305.40g/molMIK665
CAS:MIK665 (S-64315) (S-64315) has an inhibitory effect on myeloid leukemia.Formula:C47H44ClFN6O6SPurity:95.47% - 99.28%Color and Shape:SolidMolecular weight:875.41Ref: TM-T12629L
1mg126.00€5mg260.00€10mg409.00€25mg677.00€50mg954.00€100mg1,288.00€500mg2,575.00€1mL*10mM (DMSO)394.00€MIK665
CAS:MIK665 is a humanized monoclonal antibody that is used for the diagnosis of cancer. It binds to a hydroxyl group on the surface of cells, which are typically overexpressed in tumor cells. MIK665 can also induce apoptosis in primary cells, such as human immunoglobulin G (IgG) and IgM-producing B lymphocytes and T lymphocytes. The antibody has been shown to activate pro-apoptotic proteins by triggering the release of cytochrome C from mitochondria. This process leads to the activation of caspases, which are enzymes that break down protein structures within cells and lead to cell death. MIK665 has been shown to inhibit viral replication through its ability to neutralize fatty acids on the surface of viruses. Its use has also been shown to be synergistic with other drugs when used in combination with chemotherapeutic agents in metastatic colorectal cancer patients.
Purity:Min. 95%





